All In MedTech

FDA Clearance Tracker · P070022-S019

ADIANA PERMANENT CONTRACEPTION SYSTEM

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: May 27, 2011 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

May 27, 2011

Approved

Time to decision

44 days

Received Apr 13, 2011. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P070022-S019
Device name
ADIANA PERMANENT CONTRACEPTION SYSTEM
Applicant
Hologic, Inc.
Applicant location
Malborough, MA
Received
Apr 13, 2011
Decided
May 27, 2011
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P070022

Device type

Device class
Class III
Regulation
21 CFR 884.5380

Every decision under product code KNH

FDA's approval statement

As written in FDA's record.

APPROVAL OF A BACKUP STERILIZATION FACILITY LOCATED AT BIOTEST LABORATORIES, INC., IN BROOKLYN PARK, MINNESOTA.

Source documents

Other decisions for Hologic, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.